387 related articles for article (PubMed ID: 16095481)
1. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
2. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
Stevens DL; Lee MR; Padua Y
Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
7. [Neuroleptic malignant syndrome after treatment with olanzapine].
Emborg C
Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome associated with olanzapine.
Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature.
Seitz DP; Gill SS
Psychosomatics; 2009; 50(1):8-15. PubMed ID: 19213967
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
Järventausta K; Leinonen E
Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine-associated neuroleptic malignant syndrome.
Norgard NB; Stark JE
Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
Abu-Kishk I; Toledano M; Reis A; Daniel D; Berkovitch M
J Toxicol Clin Toxicol; 2004; 42(6):921-5. PubMed ID: 15533033
[TBL] [Abstract][Full Text] [Related]
14. Atypical neuroleptic malignant syndrome - A case report.
Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic-Induced Neuroleptic Malignant Syndrome After Cardiac Surgery.
Moll V; Ward CT; Zivot JB
A A Case Rep; 2016 Jul; 7(1):5-8. PubMed ID: 27191714
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Croarkin PE; Emslie GJ; Mayes TL
J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
[TBL] [Abstract][Full Text] [Related]
17. Atypical neuroleptic malignant syndrome associated with olanzapine.
Reeves RR; Torres RA; Liberto V; Hart RH
Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
[TBL] [Abstract][Full Text] [Related]
18. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
19. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]